Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.180 | 1.180 | 0.000 |
Stocks | 98.820 | 98.820 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.205 | 21.770 |
Price to Book | 4.179 | 3.989 |
Price to Sales | 2.123 | 2.260 |
Price to Cash Flow | 19.412 | 16.880 |
Dividend Yield | 1.486 | 1.345 |
5 Years Earnings Growth | 10.244 | 11.341 |
Number of long holdings: 53
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 7.07 | 12,190.0 | +1.35% | |
J&J | US4781601046 | 6.18 | 146.67 | +0.96% | |
Novo Nordisk B | DK0062498333 | 5.77 | 927.3 | +1.13% | |
Eli Lilly | US5324571083 | 5.48 | 820.34 | +0.65% | |
Roche Holding Participation | CH0012032048 | 4.74 | 231.00 | +1.18% | |
Lonza Group | CH0013841017 | 4.57 | 486.40 | -0.45% | |
Thermo Fisher Scientific | US8835561023 | 4.15 | 567.98 | +0.93% | |
UnitedHealth | US91324P1021 | 3.65 | 495.37 | +2.85% | |
Pfizer | US7170811035 | 3.07 | 28.66 | +1.63% | |
Merck&Co | US58933Y1055 | 2.80 | 125.54 | +0.81% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNB Global indeks NOK | 95.75B | 14.41 | 16.17 | 15.66 | ||
DNB Teknologi NOK | 67.46B | 16.37 | 17.90 | 23.31 | ||
NO0010801913 | 67.46B | 16.37 | 18.13 | 23.45 | ||
Pensjonsprofil 80 | 46.44B | 7.46 | 6.16 | 8.31 | ||
DNB Global IV | 44.94B | 16.25 | 17.96 | 15.96 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review